Primary aldosteronism

Kay Weng Choy¹, Peter J Fuller^{2

3

4}, Grant Russell⁵, Qifu Li⁶, Marianne Leenaerts⁷, Jun Yang^{8

3

4}

Affiliations

¹ Department of Pathology, Northern Health, Epping, Australia.
² Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.
³ Department of Endocrinology, Monash Health, Clayton, Australia.
⁴ Department of Medicine, Monash University, Clayton, Australia.
⁵ Department of General Practice, Monash University, Clayton, Australia.
⁶ Department of Endocrinology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
⁷ Governing Board, Primary Aldosteronism Foundation (primaryaldosteronism.org).
⁸ Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia jun.yang@hudson.org.au.

Kay Weng Choy et al. BMJ. 2022.

. 2022 Apr 20:377:e065250.

doi: 10.1136/bmj-2021-065250.

Kay Weng Choy¹, Peter J Fuller^{2

3

4}, Grant Russell⁵, Qifu Li⁶, Marianne Leenaerts⁷, Jun Yang^{8

3

4}

¹ Department of Pathology, Northern Health, Epping, Australia.
² Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.
³ Department of Endocrinology, Monash Health, Clayton, Australia.
⁴ Department of Medicine, Monash University, Clayton, Australia.
⁵ Department of General Practice, Monash University, Clayton, Australia.
⁶ Department of Endocrinology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
⁷ Governing Board, Primary Aldosteronism Foundation (primaryaldosteronism.org).
⁸ Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia jun.yang@hudson.org.au.

No abstract available

Conflict of interest statement

Competing interests: All authors have read and understood the BMJ policy on declaration of interests and have nothing to declare.